NASDAQ$PGNY
Progyny Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Progyny's Q3 2021 results were announced, demonstrating strong revenue growth and margin expansion.
Progyny reported a 24% increase in revenue, reaching $122.3 million for the third quarter of 2021. The company added more than 85 new clients, representing approximately 1.2 million new covered lives for 2022. Margins expanded significantly, and the company generated substantial operating cash flow.
- Revenue grew by 24% compared to the prior year period.
- Margins expanded significantly year-over-year.
- The company generated a substantial amount of operating cash flow.
- More than 85 new clients were added, representing an estimated 1.2 million new covered lives for 2022.
Headline financials
Revenue & EPS history
Progyny · Revenue · Quarterly
$122M
Revenue by segment
Progyny · $122M total across 2 segments · Q3 2021
- Fertility Benefit Services$85.3M+16.7%69.7%
- Pharmacy Benefit Services$37M+43.4%30.3%
Forward guidance
Progyny anticipates revenue growth of approximately 50% in 2022. For the fourth quarter of 2021, revenue is projected to be $133.9 million to $140.9 million, reflecting growth of 34% to 41%. Net income is projected to be $0.8 million to $3.4 million, or $0.01 to $0.03 per diluted share. Adjusted EBITDA is projected to be $16.8 million to $18.3 million.
Tailwinds
- Revenue is projected to be $133.9 million to $140.9 million, reflecting growth of 34% to 41%
- Net income is projected to be $0.8 million to $3.4 million, or $0.01 to $0.03 per diluted share
- Adjusted EBITDA is projected to be $16.8 million to $18.3 million
- Revenue is expected to be $507.0 million to $514.0 million, reflecting growth of 47% to 49%
- Net income is projected to be $51.5 million to $54.1 million, or $0.51 to $0.54 per diluted share
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
-1.1%
Avg return
Earnings day
-0.3%
Avg return
5 days after
-0.2%
Avg return
30 days after
38%
11 / 29 earnings
Positive
+26.4%
Q2 2022
Best reaction
-20.5%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.5% | +25.4% | +38.2% | |
| Q4 2025 | -20.5% | -20.0% | -22.4% | |
| Q3 2025 | +24.3% | +33.6% | +33.4% | |
| Q1 2025 | -9.7% | -6.5% | -7.2% | |
| Q4 2024 | -1.5% | -5.2% | -4.3% | |
| Q3 2024 | -18.5% | -19.3% | -12.9% | |
| Q2 2024 | -17.7% | -14.7% | -6.4% | |
| Q1 2024 | -14.4% | -14.6% | -14.2% | |
| Q4 2023 | -13.1% | -9.7% | -4.3% | |
| Q3 2023 | -4.3% | -2.1% | +17.8% | |
| Q2 2023 | +4.9% | -2.8% | -8.6% | |
| Q1 2023 | +9.3% | +5.9% | +16.8% | |
| Q4 2022 | +22.9% | +18.4% | +7.7% | |
| Q3 2022 | -2.6% | +2.0% | -13.8% | |
| Q2 2022 | +26.4% | +25.5% | +15.4% | |
| Q1 2022 | -7.1% | -15.6% | -23.1% | |
| Q4 2021 | +11.5% | +13.0% | +31.6% | |
| Q3 2021 | +2.5% | +5.8% | -22.2% | |
| Q2 2021 | -12.8% | -17.1% | +4.3% | |
| Q1 2021 | -3.2% | -8.7% | +18.4% | |
| Q4 2020 | -15.5% | -14.9% | -14.4% | |
| Q3 2020 | -0.3% | +7.0% | +38.7% | |
| Q2 2020 | +0.4% | +8.4% | -0.9% | |
| Q1 2019 | -2.4% | +4.8% | -13.7% | |
| Q1 2020 | +21.8% | +18.8% | +2.1% | |
| Q4 2017 | -3.7% | -6.3% | -8.3% | |
| Q4 2019 | -12.2% | -15.5% | -39.0% | |
| Q4 2018 | -0.2% | -5.0% | -7.0% | |
| Q3 2019 | +0.5% | +0.3% | -6.5% | |
| Q2 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro